SciSparc Gives Updates on Standing of Spin-Off of Its Late-Medical-Stage Pharmaceutical Portfolio to Publicly Traded Firm By Investing.com
Based on the letter of intent, SciSparc's pharmaceutical property are valued at…
Search
Have an existing account?
Sign In
Tag: LateClinicalStage
